Teva to Acquire Auspex in $3.2 Billion Deal

Teva agreed to acquire Auspex, increasing the Israel-based drug maker’s presence in the market for treatments for central nervous system disorders.



from WSJ.com: US Business http://ift.tt/1aavKMA

via IFTTT